Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 1/20 | 0.38 |
| ▸ | PRKDC | P78527 | 2/20 | 0.38 |
| ▸ | AHR | P35869 | 2/20 | 0.36 |
| ▸ | MAPT | P10636 | 3/20 | 0.35 |
| ▸ | MEN1 | O00255 | 2/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | HPGD | P15428 | 1/20 | 0.35 |
| ▸ | ALKBH5 | Q6P6C2 | 1/20 | 0.35 |
| ▸ | FTO | Q9C0B1 | 1/20 | 0.35 |
| ▸ | HCRTR1 | O43613 | 1/20 | 0.34 |
| ▸ | RET | P07949 | 1/20 | 0.33 |
| ▸ | HSP90AA1 | P07900 | 2/20 | 0.33 |
| ▸ | IDO1 | P14902 | 1/20 | 0.33 |
| ▸ | MMP12 | P39900 | 1/20 | 0.32 |
| ▸ | MMP13 | P45452 | 1/20 | 0.32 |
| ▸ | HSP90AB1 | P08238 | 1/20 | 0.32 |
| ▸ | NPC1 | O15118 | 1/20 | 0.32 |
| ▸ | RAB9A | P51151 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18565464 | 0.85 | PRKDC (0.41) | ALOX5PRKDCAHRMAPTMEN1 | |
| SCHEMBL18565371 | 0.85 | ALKBH5 (0.45) | ALOX5PRKDCAHRMAPTMEN1 | |
| SCHEMBL18565385 | 0.85 | ALOX5 (0.41) | ALOX5PRKDCAHRMAPTMEN1 | |
| SCHEMBL18565474 | 0.82 | AHR (0.40) | AHRMAPTMEN1KMT2AKDM4E | |
| SCHEMBL18565453 | 0.82 | TDP1 (0.38) | ALOX5PRKDCAHRMAPTMEN1 | |
| SCHEMBL18587883 | 0.82 | ALKBH5 (0.41) | MAPTMEN1KMT2AKDM4EALDH1A1 | |
| SCHEMBL22141300 | 0.81 | ALOX5 (0.49) | ALOX5PRKDCAHRMAPTMEN1 | |
| SCHEMBL18565472 | 0.81 | AHR (0.39) | PRKDCAHRMAPTMEN1KMT2A | |
| SCHEMBL18565414 | 0.80 | HCRTR1 (0.39) | ALOX5PRKDCAHRMAPTMEN1 | |
| SCHEMBL18565484 | 0.79 | ALOX5 (0.39) | ALOX5PRKDCMAPTKDM4EALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10290815-B2 | Composition, compound, material for organic electroluminescence element, ink composition, organic electroluminescence element, and electronic device | IDEMITSU KOSAN CO., LTD. (JP) | 2019-05-14 | — | — | US | disclosed |
| US-20170062733-A1 | COMPOSITION, COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENT, INK COMPOSITION, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2017-03-02 | — | — | US | disclosed |
| US-20170062733-A1 | COMPOSITION, COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENT, INK COMPOSITION, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2017-03-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10290815-B2 | Composition, compound, material for organic electroluminescence element, ink composition, organic electroluminescence element, and electronic device | EED, BMI1, CD99 | ALOX5 888/4885PRKDC 2109/4885AHR 361/4885 |
| US-20170062733-A1 | COMPOSITION, COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENT, INK COMPOSITION, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ELECTRONIC DEVICE | EED, BMI1, CD99 | ALOX5 888/4885PRKDC 2109/4885AHR 361/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.